Every Upcoming Pharmaceutical Plant
on Earth. One Database.
641 upcoming projects, followed from site selection through to validation and first batch. Capacity, dosage form, capex, EPCs, equipment orders, and verified manufacturer contacts.
As of 28 October 2026, Blackridge Research & Consulting tracks 641 upcoming pharmaceutical plant projects worldwide, representing $185 billion in announced capital expenditure.
Upcoming Pharmaceutical Manufacturing Projects Worldwide
Scroll to zoom, drag to pan, click a country to zoom into it. One dataset shades the map at a time, switch below.
Halo area is proportional to the active dataset in that region. Hover any country for the region totals that cover it.
zoom 1.0x
in the full database, filtered to your territory.
What it is
What is the Global Pharmaceutical Plant Projects Database?
A market intelligence platform tracking pharmaceutical manufacturing projects worldwide, from the first capacity commitment and incentive application through permitting, process design, construction, equipment install, qualification, validation, and commercial release. Every record carries verified investment values, production capacity, modality, timelines, stakeholders, tenders, and decision-maker contacts.
Engineering firms, cleanroom and process equipment suppliers, and contract manufacturers use it to find new facilities while design is still open, and follow each one through construction, validation and regulatory approval.
Find projects first
Coverage begins with investment incentive filings, site acquisitions, environmental permits and manufacturer capacity announcements, read in the local language before a facility is confirmed.
Know every stakeholder
Manufacturer or CDMO, engineering and construction firm, cleanroom and HVAC contractors, and process and packaging equipment suppliers are mapped to each facility with verified contacts.
Act at the right stage
Each facility carries its stage, from site selection and design through construction and qualification to validation and first commercial batch, with an alert when a watched facility moves.
Prove it before you bid
Capacity, dosage form and contract awards are reconciled against two independent sources, cited, and dated with the last verification, before they reach a record.
Pipeline Preview
10 Largest Upcoming Pharmaceutical Plant Projects Worldwide
Ranked by announced capex, these are the ten largest pharmaceutical manufacturing projects in the pipeline; each full record carries dosage form and capacity, engineering and equipment awards, and named manufacturer contacts.
| # | Project | Location | Capacity | Capex | Stage | Companies | Updated |
|---|---|---|---|---|---|---|---|
| 1 | BC - New Albany Pharmaceutical Manufacturing Plant | Ohio, United States | Not disclosed | $22B | Announced | 1 | 2026-10-02 |
| 2 | LLY - Lebanon Medicine Foundry | Indianapolis, United States | Not disclosed | $18B | On-going / Under Construction | 51 | 2026-06-11 |
| 3 | LLY - Project Savannah Biomanufacturing Facility | Texas, United States | Not disclosed | $6.5B | Planning | 4 | 2026-07-24 |
| 4 | LLY - Huntsville Medicines Manufacturing Plant | Alabama, United States | Not disclosed | $6B | Planning | 1 | 2026-07-02 |
| 5 | NOVO-B - Clayton Aseptic and Finished Product Manufacturing Plant | North Carolina, United States | Not disclosed | $4.1B | On-going / Under Construction | 11 | 2026-02-19 |
| 6 | LLY - Pleasant Prairie Pharmaceutical Manufacturing Facility Expansion | Wisconsin, United States | Not disclosed | $4B | Planning | 5 | 2026-08-16 |
| 7 | EDCL - Gopalganj Vaccine Manufacturing Plant | Dhaka Division, Bangladesh | Not disclosed | $4B | Planning | 1 | 2023-11-22 |
| 8 | LLY - Fogelsville Injectable Medicine and Device Manufacturing Facility | Pennsylvania, United States | Not disclosed | $3.5B | Planning | 1 | 2026-05-21 |
| 9 | FF - Holly Springs Cell Culture Biomanufacturing Plant | North Carolina, United States | Not disclosed | $3.2B | On-going / Under Construction | 3 | 2026-03-18 |
| 10 | LLY - Leiden Bio Science Park Pharmaceutical Manufacturing Plant | Netherlands | Not disclosed | $3B | Planning | 1 | 2026-04-03 |
Who is building
Top Pharmaceutical Plant Owners and Developers
The most active owners and developers in the pipeline, ranked by the number of projects they hold, with the stage those projects have reached. Select a company to get its full project list and verified contacts.
Blackridge Research & Consulting tracks 533 owners and developers across the pharmaceutical plant pipeline. The most active is Novartis (USA), Inc, with 9 projects.
Top 25 of 533 companies
Market intelligence
What the Pharmaceutical Plant Company Data Shows
Blackridge tracks 533 owners and developers across the pharmaceutical plant pipeline. The 25 most active hold 97 projects between them, led by Novartis (USA), Inc (9), Eli Lilly and Company, Inc. (8) and Hikma Pharmaceuticals (USA) Inc. (6).
The five busiest account for 33% of the projects held by the top 25, so the pipeline is spread across a broad field of builders rather than a few dominant ones.
All of the top 25 are owners.
Across their projects, 36% are already past contract award. Novartis (USA), Inc has the most in that phase, with 4 projects at award or under construction.
Full profiles for all 533 companies, with their project lists, contract awards and verified contacts, are in the database.
Company questions
Questions About Pharmaceutical Plant Owners and Developers
Which companies have the most upcoming pharmaceutical plant projects?
Ranked by the number of upcoming projects they hold as owner or developer, the most active pharmaceutical plant companies are Novartis (USA), Inc (9), Eli Lilly and Company, Inc. (8), Hikma Pharmaceuticals (USA) Inc. (6), AstraZeneca Plc (5) and Genentech, Inc. (4). Blackridge tracks 533 companies across the pipeline in total.
How many companies are developing pharmaceutical plant projects worldwide?
Blackridge Research & Consulting tracks 533 owners and developers with upcoming pharmaceutical plant projects. The 25 most active hold 97 projects between them.
Who is the largest pharmaceutical plant owner or developer?
By number of projects, Novartis (USA), Inc is the most active, with 9 upcoming projects as owner. Of these, 4 are past contract award and 5 in study, planning or design. Eli Lilly and Company, Inc. follows with 8 projects.
Which pharmaceutical plant companies have the most projects under construction?
Counting projects at contract award, pre-construction or under construction, the leaders are Novartis (USA), Inc (4), Gennecs LLC (3) and FUJIFILM Diosynth Biotechnologies (3).
How far along are the leading pharmaceutical plant companies' projects?
Of the projects held by the 25 most active companies, 36% are already past contract award, and the rest are in study, planning, design or announced.
How many pharmaceutical plant projects does Novartis (USA), Inc have?
Novartis (USA), Inc holds 9 upcoming pharmaceutical plant projects as owner. Of these, 4 are past contract award and 5 in study, planning or design. It ranks #1 of the 533 companies Blackridge tracks by project count.
How many pharmaceutical plant projects does Eli Lilly and Company, Inc. have?
Eli Lilly and Company, Inc. holds 8 upcoming pharmaceutical plant projects as owner. Of these, 2 are past contract award, 5 in study, planning or design and 1 announced. It ranks #2 of the 533 companies Blackridge tracks by project count.
How many pharmaceutical plant projects does Hikma Pharmaceuticals (USA) Inc. have?
Hikma Pharmaceuticals (USA) Inc. holds 6 upcoming pharmaceutical plant projects as owner. Of these, 1 is past contract award, 4 in study, planning or design and 1 announced. It ranks #3 of the 533 companies Blackridge tracks by project count.
How many pharmaceutical plant projects does AstraZeneca Plc have?
AstraZeneca Plc holds 5 upcoming pharmaceutical plant projects as owner. Of these, 2 are past contract award, 2 in study, planning or design and 1 announced. It ranks #4 of the 533 companies Blackridge tracks by project count.
How many pharmaceutical plant projects does Genentech, Inc. have?
Genentech, Inc. holds 4 upcoming pharmaceutical plant projects as owner. Of these, 1 is past contract award, 1 in study, planning or design and 2 announced. It ranks #5 of the 533 companies Blackridge tracks by project count.
Recent intelligence
New Pharmaceutical Plant Project Developments Worldwide
The latest pharmaceutical plant project news from around the world: announcements, permits, contract awards, groundbreakings and expansions, published as they are reported.
- Tillotts Pharma Plans $25.7 Million Investment to Acquire Haupt Pharma Wülfing in Gronau, Germany Acquisitions & Mergers Europe
- Kier Resumes Pre-Construction Work on $4.70 Billion H50 High-Containment Facility in Harlow, UK Laboratory Construction Europe
- Idorsia Advances Daridorexant Into Autism Research After Phase 2 Trial Reveals Unexpected Functional Benefits in Switzerland Drug Development / Clinical Trials Europe
- Sudeep Pharma's Nandesari Plant in Gujarat Clears US FDA Review US FDA Approval of Greenfield Pharma Plant Asia-Pacific
- Pathos AI Teams Up With Bristol Myers Squibb and Tempus AI to Expand AI-Driven Neuroscience Research Biotech Industry News Global
- LGM Pharma Expands GLP Bioanalysis and Impurity Testing Capabilities With Sannova Analytical Integration in New Jersey, US Mergers & Acquisitions North America
- IMUNON Strikes Up to $16.5 Million ThermoDox Licensing Deal With VoxelDox to Prioritize US Ovarian Cancer Program Asset Divestiture / Licensing Deal North America
- ESTEVE CDMO Commits Over $80 Million to New 250 m³ Manufacturing Site in Shaoxing, China Pharmaceutical Plant Projects Asia-Pacific
- DKSH Expands Healthcare Presence Across Middle East and North Africa With $390 Million NewBridge Pharmaceuticals Acquisition Mergers & Acquisitions Global
- Nouscom Secures $135 Million Series D Funding Backed by Lynch Syndrome Clinical Data Presented at ESMO in Switzerland Financing & Clinical Data Announcement Europe
- Cotecna and Energon Labs Expand Pharmaceutical Testing Capabilities in India Through Hyderabad Acquisition Mergers & Acquisitions Asia-Pacific
- Perceptive Discovery Teams Up With Atley Solutions to Expand At-211 Research Capabilities in US and UK Radiopharmaceutical CDMO Expansion Global
- Taiwan's Jyong Biotech Files Plan for Texas Plant and U.S. Operations Center Pharmaceutical Plant Projects - Asia-Pacific to U.S. Expansion (Biotech Manufacturing Investment) North America
- Millicent Pharma Invests Millions in Larne Manufacturing Expansion, Creating 20 Jobs in UK Pharmaceutical Plant Projects Europe
- Callan JMB Secures $28 Million TRUKING Equipment Order for Atlas Complex Pharma Plant in Alabama, US Equipment Procurement & Supply Chain North America
- Bio-Techne Launches GMP Small Molecule Production at New 10,000-Square-Foot Cell Therapy Facility in Bristol, UK New Plant Openings Europe
- ABIONYX Taps OLON for CER-001 Validation Batches at Two France Sites Contract Manufacturing & Validation Batches Europe
- Danaher Launches Autonomous AI Antibody Lab to Speed Discovery Eightfold Artificial Intelligence Global
- Piramal Pharma Solutions Commissions Microbiology Lab at $85 Million Lexington Expansion Site in Kentucky, US Pharma Manufacturing & Facility Expansion North America
- Fujifilm Expands Japan ADC Manufacturing With New Linker-Payload Equipment at Fukushima Plant Pharmaceutical Manufacturing Capacity Expansion Asia-Pacific
- Orion Pharma Invests Over $112 Million to Upgrade Four Finland Manufacturing Sites Pharmaceutical Plant Projects Europe
- Edinburgh CDMO RoslinCT Wins up to $9.59 Million Scottish Enterprise Grant for Digital Manufacturing Push Funding & Grants Europe
- Hovione Invests $35 Million in Continuous Tableting Line at New Jersey, US Site Continuous Manufacturing Equipment Investment North America
- GE HealthCare to pay $945 Million in cash for PET radiopharmaceutical maker SOFIE Biosciences in US Mergers & Acquisitions North America
- Dunbar Pharma Plans 2027 API Manufacturing Expansion in Ireland Pharmaceutical Manufacturing & Product Launches Europe
- Kyrgyzstan Signs Memorandum for $1 Billion Pharmaceutical Industrial Park Kyrgyzstan Asia-Pacific
- BMK Pharma Set to Begin Interior Work on Allen Headquarters and Sterile Drug Production Site New facility construction (sterile drug manufacturing site) North America
- Uttarakhand Governor Inaugurates J.K. Lifecare Centres' New API and Intermediates Manufacturing Facility in Ujjain, India New Facility Opening Asia-Pacific
Market Intelligence
Upcoming Production Capacity and Investment by Region
Global Pipeline by Development Stage
Nine stages in four phase families, each cell sized by the number of tracked projects at that stage, running from the earliest signals through to validation and first batch.
| Stage | Projects | Capacity | CapEx |
|---|
Project Density by Region
Where the tracked pipeline actually sits. Counts come straight from the live database and are compared against the busiest region, not against a total: the regions overlap, so they are never added together.
Bars are scaled to the busiest region. A project in a country belonging to more than one grouping is counted in each, so these figures are not additive.
Market intelligence
Pharmaceutical Plant Pipeline by Stage and Region
Of the 641 upcoming pharmaceutical plant projects tracked, 35% are at contract award, pre-construction or under construction, 52% are in study, planning or design and 13% have only been announced. Planning is the largest single stage, with 283 projects.
The 224 projects past contract award carry $83 billion in capital expenditure, the part of the pipeline where equipment and construction packages are being let now.
Projects past award average $371 million each, against $204 million for those still in study, planning or design.
Europe holds the most tracked projects, 213 or 33% of the pipeline, followed by Asia-Pacific (173) and North America (170).
By announced investment, North America leads with $121 billion and also has the largest average ticket, $710 million per project.
Construction is furthest along in Africa, where 43% of tracked projects are past contract award, compared with 17% in Latin America.
Every project behind these figures, with its stage history, contractors and verified contacts, is in the full database.
FAQ
Questions Pharmaceutical Teams Ask
About the database
Coverage and data
Market fundamentals
Data quality and methodology
Plans and getting started
Get Started
Start Tracking the Global Pharma Manufacturing Pipeline
Join equipment makers, engineering firms, EPCs, and investors who use the database to stay ahead of the worldwide manufacturing build-out.